This trial is conducted in Asia. The aim of this trial is to evaluate the new liquid somatropin formulation in children with growth hormone deficiency.

Inclusion Criteria:

• Written Informed Consent by patient and/or guardian/parents
• Patients with one of the following diagnosis: Growth failure due to growth hormone deficiency (GHD), Turner syndrome, or growth retardation in children with chronic renal disorders
• Patients who are willing to inject themselves and answer questionnaires or young patients whose parents/guardian are willing to inject their child and answer questionnaires
• Patients on growth hormone therapy for at least 6 weeks before entering the trial

Exclusion Criteria:

• Pregnancy or breast feeding women
• Suspected or known allergy to trial product
• Other daily injection therapy (non-growth hormone, e.g insulin-therapy)
• Participating in any other trial involving other investigational products within the last 3 months